Method and system for monitoring tissue ablation by constrained impedance measurement
By measuring the impedance changes of the current path during catheter ablation therapy, and utilizing a combination of multiple external electrodes and catheter electrodes, tissue damage can be monitored in real time, solving the problem of the lack of reliable damage assessment in existing technologies and achieving high-precision damage monitoring and treatment control.
Patent Information
- Application Number
- CN202080027495.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2020-04-02
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2040-04-02
AI Technical Summary
Current technologies lack reliable means to monitor tissue damage development in real time during cardiac catheter ablation, especially when not relying on electrical impedance tomography and CT imaging, making it difficult to accurately assess the size and location of damage.
By measuring the impedance change of the current path between the catheter ablation device and the patient's body, and using a combination of multiple external electrodes and catheter electrodes, tissue damage can be monitored in real time. Impedance measurement is performed using four-terminal sensing technology and an electrical controller, and machine learning and regression analysis algorithms are combined to provide real-time assessment of the size and shape of the damage.
It achieves high-precision damage monitoring within a depth of 1 mm and an error of 3 mm, providing real-time and reliable assessment of damage size and shape, avoiding the need for complex image reconstruction and CT imaging, and ensuring the accuracy and safety of treatment.
Smart Images

Figure CN113645915B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to methods and systems for monitoring tissue ablation by constrained impedance measurement. It has particular application in real-time continuous assessment of intravascular cardiac catheter ablation therapy, but may also find application in various other medical treatment techniques. Background Art
[0002] Cardiac catheter ablation, such as radiofrequency (RF) ablation, can treat a wide range of arrhythmias in a minimally invasive manner and constitutes a rapidly growing area of interventional cardiology. The heart regions involved in these arrhythmias can be reached via entry from a peripheral vein or artery with a catheter equipped with a suitable ablation device (such as RF radiating electrodes or other suitable instruments) and can be ablated by applying ablative energy to heat the tissue.
[0003] RF catheter ablation involves delivering high frequency alternating current (in the range of 350kHz to 1MHz) to myocardial tissue through one or more electrode catheters to produce thermal lesions. The mechanism by which the current heats the tissue is resistive (ohmic) heating of a narrow edge (<1mm) of tissue in direct contact with the electrode, with deeper tissue areas heated by conduction. Heat is dissipated from this area by further thermal conduction into normothermic tissue and by thermal convection through the circulating blood pool.
[0004] Lesions that are too small may be ineffective in treating arrhythmias, while lesions that are too large may be associated with unwelcome complications. Overheating in this area is a major problem, with potential risks including puncture and tamponade. Therefore, successful catheter ablation requires not only precise localization of the arrhythmogenic substrate, but also complete and permanent elimination of that substrate without collateral damage.
[0005] Although it is desirable to monitor lesion progression during an ablation procedure, there is currently no reliable means to accomplish this clinically. Surrogate measurements (such as catheter tip temperature and impedance changes, ablation power, duration, catheter tip pressure, and reductions in the intracardiac electrocardiogram recorded on the ablation catheter) can provide an indication that the catheter tip is properly positioned relative to the heart wall and that ablation is occurring, but generally do not provide any direct measure of lesion formation or progression. MRI can provide high-resolution images of lesions with relatively small errors, but image reconstruction times are long (up to 30 minutes), making this technology impractical for standard clinical procedures.
[0006] Previous systems for determining lesion size include the use of electrical impedance tomography (EIT). EIT suffers in its traditional implementation because it is an ill-posed method that produces low spatial resolution results. Therefore, EIT-implemented systems rely heavily on CT imaging or position information throughout the treatment process, which is utilized in addition to real-time catheter position knowledge.
[0007] What is needed is a more reliable system and method for monitoring lesion development during catheter ablation without a numerical solution for EIT or without resorting to CT information.
[0008] The reference to any prior art in this specification is not an acknowledgement or suggestion that this prior art forms part of the common general knowledge in any jurisdiction, or that this prior art could reasonably be expected to be combined with any other prior art by a skilled reader. Summary of the invention
[0009] During the delivery of electromagnetic radiation in a catheter ablation procedure, temperature changes in cardiac tissue due to resistive and conductive heating are accompanied by changes in the electrical impedance of the tissue. In theory, when temperature increases, impedance decreases. This allows real-time measurement of heating in a tissue volume by measuring the changed impedance of the tissue volume.
[0010] According to the present invention, in a first aspect, there is provided a system for monitoring the development of tissue damage during a medical ablation procedure applied to a patient, the system comprising:
[0011] A catheter ablation device having at least one catheter electrode;
[0012] The device is connectable to a source of electrical energy via an electrical feedthrough and is configured to apply ablative energy to ablate tissue in a target area;
[0013] a plurality of external electrodes for application to a patient's body;
[0014] measurement circuitry for determining an electrical characteristic of a current path between at least one catheter electrode and an external electrode in the absence of application of said ablation energy; and
[0015] Electric controller.
[0016] Preferably, the electrical characteristic is the impedance of the current path.
[0017] In a preferred form, the electrical controller is arranged to control the application of an AC current source between different combinations of at least one catheter electrode and a plurality of external electrodes such that measurements of the resulting voltages provide measurements of the impedances of different electrical pathways through the patient's body between the various electrodes, and the electrical controller is further configured to disconnect the catheter ablation device from the source of electrical energy or otherwise suspend said application of ablation energy during application of said AC current source.
[0018] The system may include a virtual resistive load for selectively connecting to a source of electrical energy during an operating period of the measurement circuit. In this case, an ablation shunt may be included that is configured to decouple the energy source from the catheter ablation device and couple it to the virtual load.
[0019] Alternatively, an intermittent source of electrical energy may be used which can be quickly switched off during the period when measurements are being taken.
[0020] In a preferred form, the measurement circuit comprises a switch matrix arranged to switch between different electrode combinations under the control of the electrical controller.
[0021] Preferably, the measurement circuit is configured to perform four-terminal sensing to measure the electrical characteristic (eg impedance).
[0022] The electrical controller may include a PC. In a preferred form, the measurement circuit includes one or more analog-to-digital converters (ADCs) to provide a digital representation of the measured voltage. In one embodiment, multiple ADCs are included for measuring different current paths simultaneously, each ADC being arranged to switch between different selected external electrodes under the control of the electrical controller.
[0023] In one form, the source of electrical energy is an RF generator.The present invention may also be applied to other types of ablation procedures, including microwave ablation and electroporation.
[0024] The plurality of external electrodes may be arranged as an electrode dot harness for application across an external region of the patient's body.
[0025] According to the present invention, in a second aspect, there is provided a method of operating a system for monitoring the size of a lesion during a catheter ablation procedure applied to tissue of a subject, the method comprising:
[0026] (a) performing an ablation phase involving delivering ablative energy to a catheter electrode;
[0027] (b) performing a measurement phase involving measuring electrical characteristics of current paths through the lesion region formed by the ablation;
[0028] Wherein, steps (a) and (b) are repeated sequentially.
[0029] In a preferred form, steps (a) and (b) are repeated sequentially until the measurements performed in step (b) indicate a specified lesion size.
[0030] In step (b), ablation energy may be transferred from the catheter electrode to the dummy load.
[0031] The method of the second aspect of the present invention may include using the system of the first aspect of the present invention, wherein step (a) is performed using the catheter ablation device, and step (b) is performed using the multiple external electrodes and the measurement circuit, and switching between steps (a) and (b) is performed under the control of the electrical controller.
[0032] Thus, according to the method, the measurement phase involves sequentially passing current between one or more catheter electrodes and a plurality of electrodes applied external to the patient's body and measuring the electrical response. Analysis of the results provides an assessment of the effectiveness of the most recent ablation phase, and analysis of the results of successive measurement phases allows predictions regarding the expected lesion size to be obtained.
[0033] The method may include an initial determination phase in which one or more current paths are selected from a plurality of current paths by sequentially applying current between one or more catheter electrodes and a plurality of external electrodes applied to the patient's body and measuring electrical responses, and electrodes for step (b) are selected based on the results.
[0034] Preferably, a defined number of current paths are selected in the determination phase, wherein the associated electrodes are used for subsequent iterations of step (b).
[0035] In one embodiment, the electrodes are selected as those associated with the lowest impedance of the current path being measured. Alternatively, the electrodes may be selected as those associated with the current path that are most sensitive to a local state change in the patient's body, such as the injection of a conductive solution into an area adjacent to the injury.
[0036] The change in impedance can be compared to previously determined data (e.g., in a lookup table) to provide a measure of lesion size to the medical practitioner. Testing has shown that the method of the present invention can be used to track lesion size within an error of only about 1 mm deep and 3 mm long, which is considered clinically acceptable in most applications.
[0037] In a preferred form, the method includes using the measurements made in step (b) in an algorithm to estimate the size of the lesion formed in step (a).
[0038] In one embodiment, for each measurement phase, the measurement results are analyzed and a selection is made of which measurements to use in the algorithm.
[0039] The selection may be made based at least in part on a change in the electrical characteristics of the relevant current path since a previous measurement phase.For example, the selection may be made based on the maximum impedance drop caused by an interventional ablation phase.
[0040] In a preferred form, step (a) and / or step (b) may be gated to the subject's breathing cycle and / or heartbeat so that the measurement phase is performed at a relatively stable point.
[0041] The algorithms used in the analysis of the measurements may include regression analysis algorithms. Alternatively or additionally, machine learning may be used to interpret the results. As will be appreciated, analysis of the results (particularly based on the position of the external electrodes used for each measurement) may be used in the determination of lesion size, lesion shape and / or lesion orientation.
[0042] The present invention therefore relates to impedance measurement between an ablation catheter electrode and a plurality of external electrodes. In this specification and in the claims, the term "external electrode" is used to refer to a secondary electrode group remote from the catheter. In common applications, the external electrodes are placed outside the patient's body and in contact with the patient's body. However, it will be understood that they can be placed within internal structures of the body, such as the esophagus, coronary sinus or other suitable locations. The catheter electrodes and external electrodes are used to quickly and reliably find the most clinically important current paths, and to obtain measurements of impedance changes as ablation is performed, which can provide clinically useful indications of lesion growth.
[0043] The use of multiple impedance measurements between multiple electrodes in different locations on the patient's body is of course known in the general field of EIT. However, EIT is used in medical imaging, particularly in areas such as monitoring lung function, localization of cancerous areas, brain activity and localization of gastric activity. In contrast, the present invention does not rely on image reconstruction software, but instead uses a combination of (one or more) electrodes included in the ablation catheter with multiple external electrodes and a specially configured switching device to determine which electrode group (corresponding to a specific conductive path) to use when continuously monitoring the effectiveness of the use of the ablation catheter, the response in the measured electrical characteristics of these current paths providing a relatively direct real-time indication of the progression of lesion formation. As with EIT, the current applied in the method of the present invention is typically relatively small and at a suitably high frequency to avoid significant neural stimulation or ohmic heating within the body. Unlike the use of EIT to monitor lesion formation, the present invention does not require complex computational solutions and does not require recourse to CT imaging or position information.
[0044] The proximity of the catheter electrode(s) establishes that the heated volume is included in the resulting electrical path to the external electrode(s), and in accordance with the present invention, the most appropriate current path is found by iteratively applying current across the plurality of electrodes and performing voltage measurements. A specified criterion, such as the lowest calculated impedance measurement, is considered indicative of the most appropriate path for monitoring lesion formation during ablation therapy. BRIEF DESCRIPTION OF THE DRAWINGS
[0045] Further aspects of the invention and further embodiments of the aspects described in the preceding paragraphs will become apparent from the following description given by way of example and with reference to the accompanying drawings, in which:
[0046] Figure 1 is an overview of a system for monitoring lesion development during RF catheter ablation of a patient according to one embodiment of the present invention.
[0047] Figure 2 Depicts the connection to the RF generator Figure 1 ablation interface of the system.
[0048] Figure 3 Describes alternative interfaces to the system.
[0049] Figure 4 is a flow chart illustrating a method for monitoring lesion development during catheter ablation according to one embodiment of the present invention.
[0050] Figure 5 yes Figure 4 Flowchart of the measurement phase of the method shown.
[0051] Figure 6is a flow chart illustrating a method for monitoring lesion development during catheter ablation according to an alternative embodiment of the present invention.
[0052] Figure 7 yes Figure 6 Flowchart of the measurement phase of the method shown.
[0053] Figure 8 An embodiment of 64 ECG electrodes ("point electrodes") arranged in 16 quad strips is shown.
[0054] Fig. 9 is a schematic diagram of the catheter device and ablation lesion. DETAILED DESCRIPTION
[0055] It will be understood that the invention disclosed and defined in this specification extends to all alternative combinations of two or more of the individual features mentioned or evident from the text or drawings. All these different combinations constitute various alternative aspects of the invention.
[0056] Figure 1 The system 10 shown provides monitoring of lesion development during RF catheter ablation and comprises an RF ablation catheter 3 (comprising an RF radiator and an RF power supply line) for introduction into a heart chamber of a patient 11. The catheter 3 is provided with catheter electrodes E1, E2, E3, E4, the electrode E1 comprising an RF ablation electrode (see Fig. 9 ), while the patient return electrode 2 is attached to the patient's thigh or other suitable location. As discussed further below, the band 4 of the outer surface electrode 1 is wrapped around the patient's chest. The outer electrode 1 can be a traditional ECG point electrode, in which case it is used to measure voltage.
[0057] The ablation catheter 3 may be, for example, a 3.5 mm Fr Thermocool catheter (Biosense Webster Inc.), a Therapy Cool Flex ablation catheter, or any other suitable device known to those skilled in the art. The ablation generator 12 may be, for example, a Stockert 70 cardiac ablation radiofrequency generator St4520 (Biosense Webster Inc.).
[0058] The electrical interface module 6 (also labeled 6A with respect to the embodiment 2 of the present invention, discussed further below) includes a plurality of relays and N-way switches (e.g., a switch matrix 16 / 16A, included in the impedance measurement circuit 17 / 17A (see Figure 2 and Figure 3 ) in which the electrical interface module 6 is configured to manage the ablation phase and the measurement phase of the treatment of the patient 11.
[0059] Switch control is provided by a PC running a custom computer program (not shown). The output of the RF generator 12 is referred to as the input 5 of the interface module 6 / 6A. In addition, the interface module 6 / 6A is electrically connected to the patient return electrode 2 via a lead 9, to each external electrode 1 of the electrode belt 4 via an external electrode lead 8, and to each internal electrode E1, E2, E3, E4 of the catheter 3 via a lead 7 by means of a cable connector 13.
[0060] In addition, the system may also include a real-time ECG / QRS (heartbeat) detector 102 having ECG electrodes 101 placed on each wrist of the patient. The ventilator 100 may be used to ventilate the anesthetized patient 11 during the ablation procedure, in which case the ventilator 100 is configured so that the respiratory cycle measurements are received by the computer program. Alternatively, if the patient 11 is only in a sedated state, a signal indicative of respiratory function received from another source, such as fluctuations in chest wall impedance, may be used.
[0061] Example 1
[0062] Figure 2 1 shows a first embodiment of the circuitry of the electrical interface module 6 connected to the RF generator 12. The ablation shunt 24, relay 19 and relays in relay groups 20, 21, 22 (collectively referred to as relay group 23) are shown in impedance measurement positions. The N-way switches of the switch matrix 16 are shown set at arbitrary positions, however during the "measurement phase", the switches will cycle through multiple positions, as described in detail below.
[0063] The switch matrix 16 consists of four N-way steering switches 18A, 18B, 18C, 18D. In the example configuration, switches 18A and 18B are 4-way switches, where the throw of each switch provides a connection to each of the catheter electrodes E1-E4. Switches 18C and 18D are 64-way switches, but for ease of depiction, only four terminals are shown. The throws of switches 18C and 18D provide a connection to each of the 64 external surface electrodes 1. These N-way steering switches 18A, 18B, 18C, 18D together allow the terminals of the AC constant current source 15 and the high-precision voltmeter 14 (with an output via an ADC) to be selectively connected to any one of the catheter electrodes E1-E4 and the external electrode 1.
[0064] An appropriate operating frequency of the AC current source 15 is used, as determined based on competing factors. The frequency must be high enough to avoid tissue irritation and allow acquisition of several measurement cycles in a short period of time, but the frequency must also be low enough to minimize the effects of parasitic capacitance within the catheter and to minimize any interference from the applied frequency of the ablation energy. In initial testing, the inventors found that frequencies in the range of 50kHz-100kHz are preferred. The amplitude of the injected current is also appropriately selected, as determined by competing factors. Higher currents provide better voltage resolution, especially for low impedance paths, however the current should not be so high that the electrode itself begins to heat up. In initial testing, the inventors found that currents in the range of 2-5mA are preferred.
[0065] Thus, the measurement circuit 17 is configured to perform sequential four-terminal impedance measurements. To perform each measurement, a current is supplied between the first catheter electrode E1 / E2 / E3 / E4 and the first external electrode 1, and the resulting voltage is measured between the second catheter electrode and the second external electrode adjacent to the first external electrode. The resulting impedance is then transferred from the USB output of the ADC voltmeter 14 to an external PC (not shown).
[0066] exist Figure 8 In the example configuration shown, the electrode strip 4 consists of four rows of 16 outer "dot" electrodes 1. The groups of electrodes directly adjacent to electrodes "a" and "b" are indicated by dashed and dotted outlines, respectively. As will be noted, electrode "a" (like all other electrodes in the upper or lower rows) has five directly adjacent electrodes, while electrode "b" (like all other electrodes in the center row) has eight directly adjacent electrodes. The electrode strip 4 is arranged in a row. Figure 8 It is shown flat in FIG, but it will be understood that in use it is wrapped around the patient's chest so that the leftmost and rightmost electrodes depicted are adjacent electrodes to each other.
[0067] As an example four-terminal arrangement, an impedance measurement is obtained in the conductive path between the catheter 3 and the electrode "a" by connecting the positive terminal I+ of the current source 15 to the catheter electrode E3, connecting the negative terminal I- of the current source 15 to the external electrode "a", connecting the positive terminal V+ of the ADC voltmeter 14 to the catheter electrode E2, and connecting the negative terminal V- of the ADC voltmeter 14 to any of the five external electrodes 1 adjacent to the electrode "a". Thus, any one of the five measurements can provide a determination of the current path to the catheter associated with the electrode "a", and the method of the present invention uses all five measurements to determine the most appropriate. The same applies to any electrode in the upper or lower row of the electrode strip 4.
[0068] Similarly, for electrode "b" (or any other electrode in any of the middle rows of electrode strip 4), any one of the eight measurements can provide a determination of the current path to the catheter associated with that electrode, and the method of the present invention uses all eight measurements to determine the most appropriate. Impedance measurements are discussed further below with reference to the calibration phase and measurement phase of the method of the present invention.
[0069] Return to Figure 2 , the ablation shunt 24 consists of two SPDT (single pole double throw) relays 19, which operate simultaneously to direct the electroablation power from the RF generator 12 to the catheter electrode E1 and the return electrode 2, or to a dummy load 25 (e.g., a 10Ω resistor) while the measurement is being performed. The SPDT relay 19 can be, for example, a G6EK-134P-ST-US-DC5 (Omron Electronics) relay. This arrangement provides protection for the measurement circuit 17 and other components from high voltage and RF noise.
[0070] In addition, ablation isolation relay groups 20, 21, 22 (collectively referred to as relay group 23) are arranged to operate synchronously with ablation shunt relay 19. During ablation, ground relay 20 connects the throw of the N-way switch of switch matrix 16 to ground. Isolation relay 21 isolates external point electrode 1 from catheter electrodes E2 to E4. Relay 22 connects the catheter tip electrode E1 and the return electrode to the corresponding throw of the ablation shunt relay.
[0071] In one state (in which impedance measurements can be made), relay groups 20 and 21 together allow connection from the throws of switches 18A, 18B to each catheter electrode E1-E4 and connection from the throws of switches 18C, 18D to each external electrode 1, while the return electrode 2 is disconnected from the catheter tip electrode E1 (as shown).
[0072] Therefore, the ablation shunt relay 19 and the ablation isolation relay of the relay group 23 enable the system to switch between two states, namely the ablation state and the measurement state. The method of the present invention involves an iterative process of cycling between these two states, as described below with reference to Figure 4 Discuss the present embodiment with respect to it.
[0073] Figure 4 The process shown involves a setup phase, followed by a determination phase, followed by repeated ablation phases and measurement phases, which are continued until the desired lesion size is achieved (as determined using voltage / impedance measurements), at which time treatment is stopped.
[0074] Setting up the stage
[0075] The first step in the process is a setup phase 41 during which the AC current source 15 and ADC voltmeter 14 are used to obtain a four-terminal inside-to-outside voltage measurement using each of the two electrodes of the catheter 3 and the external electrode 1. The purpose of the setup phase is to obtain measurements of all possible electrical paths between the internal and external electrodes to allow determination of the best path for the measurement being made. As will be appreciated, for an injection of a known current, the measured voltage provides a determination of the impedance of the current path.
[0076] As discussed above, the voltage measurement results generated by the applied current are obtained for the electrical path between the catheter and the external electrode. Ablation catheters (such as the Webster Biofunctional Thermocool ablation catheter) typically have four catheter electrodes, however only two internal electrodes are required for four-terminal voltage measurements. In the described example, E2 and E3 are used to perform the measurement, where E1 is only used for ablation and E4 is not used. The inventor believes that E4 is too far from the catheter tip, and testing has shown that in practice, the impedance measurement results using E1 are often undesirable noise, which may be due to the isolation limitations provided by the ablation shunt 24 from the RF signal to E1.
[0077] Return to Figure 2 , to obtain a four-terminal impedance measurement, I+ is connected to catheter electrode E3, V+ is connected to catheter electrode E2, I- is connected to the first external electrode 1, and V- is sequentially connected to each electrode adjacent to the first external electrode. The resulting voltage measurement for each is recorded. I- is then switched to connect to the second external electrode 1, where V- is sequentially switched to the electrodes adjacent to the second external electrode. This continues until current has been applied and the resulting voltages of all external electrodes are measured and recorded.
[0078] As described above, a plurality of four-terminal voltage measurements are performed for each external electrode 1, involving electrodes adjacent to each external electrode. Figure 8 In the configuration shown (strip 4 consisting of 64 electrodes arranged in four rows of 16 electrodes each), a total of 416 impedance measurements and paths were recorded (five for each electrode in the top and bottom strips, and eight for each electrode in the middle strip).
[0079] Determine the ablation measurement path
[0080] Back to Figure 4 , the process then proceeds to a determination step 42 where the results from the setup phase are analyzed to make a decision regarding the 10 most appropriate catheter to external electrode paths.
[0081] Since lower impedance generally indicates a more direct path and associated lower noise risk, the "best" path is considered to be the path of lowest impedance. However, it will be appreciated that in alternative approaches other criteria may be used.
[0082] For example, a path may be selected that exhibits the highest sensitivity for introducing an appropriate saline solution to the catheter site.
[0083] As discussed further below, rather than selecting a single internal-to-external electrode path, step 42 involves determining 10 paths so that if a path is found to be unreliable (e.g., due to the presence of lung fields), other measurement paths are available. As will be appreciated by those skilled in the art, any number of internal-to-external electrode paths may be selected, and the inventors determined that ten paths provide an appropriate and feasible number of alternatives for the method of the present invention. As will be appreciated, selecting more paths will involve longer monitoring times, while selecting fewer paths may introduce random errors.
[0084] In an alternative approach discussed below with respect to Example 2 of the present invention, rather than determining a limited number of paths for impedance measurement during the ablation process, all path impedances may be measured at each measurement stage, with specified criteria determining which paths are used in the analysis.
[0085] Ablation phase
[0086] Once step 42 is determined to be complete, RF ablation therapy begins (ablation phase 43). As discussed above, during this phase, the ablation isolation relay 21, i.e., under the control of the PC, disconnects the catheter electrode and the external electrode 1 from the impedance measurement circuit 17. The ablation isolation ground relay 20 connects the catheter electrode and the external electrode terminal of the N-way switch 18 to ground.
[0087] The ablation shunt relay 19 and the ablation isolation relay group 22 provide RF ablation energy from the RF generator 12 to the catheter tip radiator electrode E1, the patient return electrode 2 to provide an electrical return path. The RF ablation energy is applied for a suitable time to heat the tissue to initiate lesion formation. In experimental testing, various factors including the patient's respiratory rate were selected to select an ablation duration of 5.2 seconds, as discussed in more detail below.
[0088] After each ablation phase, a relay circuit is used to switch the RF generator 12 from the catheter tip electrode E1 and the patient return electrode 2 to the dummy load 25; a 50 ms pause while this switch occurs provides time for the area around the developing lesion to thermally equilibrate. During this time, the peripheral venous or arterial fluid / blood heated during the ablation phase flows away from the catheter tip area so that any thermal changes occur only in the lesion.
[0089] Measurement Phase
[0090] The measurement phase 44 is used to measure the resulting voltage when current is applied from the inner electrode of the selected path to the outer electrode while the ablation treatment is ongoing (i.e., between successive ablation cycles), thereby providing a measure of the size of the lesion. After a 50 ms delay at the end of the ablation phase, the RF generator 12 switches from the catheter tip electrode E1 and the patient return electrode 2 to the dummy load 25.
[0091] Under control of the PC, the switch matrix 16 forms connections to enable continuous four-terminal voltage measurements on the ten measurement paths selected in the determination phase 42 .
[0092] Figure 5 The flowchart of provides further details of the measurement phase 44. Because tissue impedance will decrease with increasing temperature due to ablation within the tissue, if any of the 10 impedance measurements shows an increase in impedance between the current measurement and the most recent measurement (in the setup phase or the most recent measurement phase), the impedance value should be ignored. An increase in impedance can indicate that the path has a low signal-to-noise ratio (SNR) or that the measurement is dominated by unexpected events or noise.
[0093] refer to Figure 5 , the measurement phase process begins with respect to the first measurement path (i.e., path i=1) (step 50). Under control of the PC, the switch matrix 16 is configured to make a single four-terminal voltage measurement (step 51) of the first path identified in the decision step 42, which is used to determine the impedance. This value is then compared to the stored previous value in a decision step 52. If this new impedance measurement of the first path is lower than the previous value, then this measurement is used (step 53) as an indication of the size of the damage. If the new impedance measurement is higher than the previous value, then this value is discarded (step 54).
[0094] The impedance is then measured and determined for the next path by incrementing the count (i=i+1; step 58) and repeating the process. Decision step 59 determines whether all 10 paths have been measured, at which point the process moves to decision step 57. If it is determined that none of the 10 impedance values are lower than their previous measurements, then the lesion can be considered to be the same size as the previous cycle (step 55). This can indicate that the ablation has failed and needs to be repeated, however, near the end of the ablation process, an equilibrium state is reached and the lesion is no longer growing significantly. Of course, the decision to continue the ablation will be made by the cardiologist / surgeon as informed by the impedance measurements.
[0095] If it is determined (step 57) that at least one impedance measurement has been marked for use (i.e., the impedance of that particular path has decreased, indicating an increase in lesion size), the PC uses the impedance measurement to make a lesion size determination using a predefined set of impedance depth and width curves (step 56).
[0096] To exclude possible under- and over-estimates, quantiles of the depth and width groups with cumulative probabilities of 0.45 to 0.55 were used to constrain the results. These were expanded to 0.35 to 0.65 and then to a maximum of 0.25 to 0.75 until at least one measurement was found to fall within this range. Thus, the final measured lesion size would represent the average depth and width.
[0097] Fig. 9 A schematic diagram of a catheter 3 is provided, wherein electrodes El, E2, E3, E4 are positioned proximate to a lesion 90 in tissue 91, the lesion width and height being determined by the method of the present invention.
[0098] Back to Figure 4 , after the measurement phase 44, a determination of the lesion size after the most recent ablation cycle is made. At decision step 45, if it is determined that the lesion has the desired size, the ablation treatment process ends. If the desired lesion size has not been reached, the surgeon / cardiologist may decide to start the next ablation iteration, so the process returns to the ablation phase 43.
[0099] As will be appreciated, this repeated alternation of ablation and impedance measurement cycles provides real-time continuous monitoring of the progress of the treatment, but without the RF field interfering with the measurement equipment (or vice versa).
[0100] Example 2
[0101] In this alternative embodiment, Figure 3 1A and 1B are schematic diagrams of the circuitry of the electrical interface module 6A connected to the RF generator 12A. The ablation shunt relay 19A and the relays of relay groups 31 and 32 are shown in the impedance measurement position. The N-way switches of the switch matrix 16A are shown set to an arbitrary position, however during the measurement phase the switches will again cycle through multiple positions.
[0102] The switch matrix 16A is composed of a plurality of N-way steering switches 30 and 30A to 30X. Unlike the arrangement of Embodiment 1, the I+ of the current source is not connected to the four-way switch, but is connected only to the electrode E2 via the ablation isolation relay, and the V+ is similarly connected only to the catheter tip electrode E1 via the ablation isolation relay. The pole of the steering switch 30 is connected to the I- terminal of the current source, and the poles of the switches 30A to 30X are connected to the V- terminals of a plurality of analog-to-digital converters (ADCs) 14A-14X.
[0103] In this embodiment, the inventors' improvements to the device (particularly in providing more reliable rapid switching to isolate the RF generator from the catheter) mean that (unlike in Example 1) the catheter tip electrode E1 can be used as the impedance measurement electrode. This is preferred because E1 is the catheter electrode closest to the ablation zone.
[0104] For ease of illustration, only three terminals of the N-way switch are shown. The throws of switches 30 to 30X are connected to the external point electrodes 1 to N of electrode strip 4. In this embodiment, the N-way pilot switch of measurement circuit 17A allows four-terminal impedance measurements to be made in parallel, thereby reducing the length of time required to measure all impedance paths (a total of 416 paths in this embodiment).
[0105] During the measurement phase, the I-terminal of the current source is sequentially connected to each external point electrode, while the (one or more) V-terminals are connected to the adjacent point electrodes of the current source I-terminal position. For example, the measurement circuit 17A may include 8 ADCs (ADC1-ADC8), with 8 corresponding N-way switches 30A to 30H, and thus a total of 9 N-way switches (including switch 30) in the switch matrix 16A. As will be appreciated, in this manner, for each I-terminal position of the AC current source 15, all 8 adjacent electrodes can be measured simultaneously, thus significantly reducing the overall sampling time.
[0106] The ablation shunt relay 19A is a SPDT (single pole double throw) relay, as used in Embodiment 1, which again operates simultaneously to direct the electroablation power from the RF generator 12A to the catheter electrode E1 and the return electrode 2, or to a dummy load 25 (e.g., a 10Ω resistor) while measurements are being performed. This arrangement provides protection for the measurement circuit 17A and other components from high voltage and RF noise.
[0107] Furthermore, the grounding relay 31 is arranged to operate synchronously with the ablation shunt relay 19A. Thus, the ablation shunt relay 19A and the grounding relay 31 enable the system to switch between two states, namely the ablation state and the measurement state. Again, the method involves an iterative process of cycling between these two states, as described below with reference to Figure 6 discussed.
[0108] To avoid noise from the RF generator 12A in the impedance measurement, the relays of the relay group 32 disconnect the catheter electrodes E2 to E4 from the RF generator during the measurement phase. However, during the ablation phase, the physician can use the signals from E2, E3 and E4 to confirm the catheter position, although position determination does not form part of the present invention.
[0109] The process of selecting 10 measurement paths described above with reference to Example 1 is intended to reduce the measurement cycle time. This is particularly relevant if the impedance measurement may be affected by power line interference and the measurement duration must be selected to take into account such interference. For example, a duration of 5 power line cycles may be suitable to reduce the effects of interference. For a 50 Hz mains frequency, the time for making one measurement (measurement period) may therefore be 100 ms (5×1 / 50 Hz). In the case where power line interference is not significant, the inventors have determined that a measurement duration of 2.5 ms is suitable.
[0110] Thus, in this embodiment, a shorter measurement interval combined with the use of parallel switching allows all N electrodes to be used in each measurement phase without undesirably interrupting the ablation process. The specific connection pattern in which this occurs can be arranged by the sequencer so as to allow a minimum number of changes in each switch position. To this end, very fast solid-state switches are used for the N-way switches 30A-30X.
[0111] In this embodiment, since all path impedances are measured during the measurement phase (rather than a preselected subset of the paths), there is no need to perform a separate setup phase. Figure 6 , which depicts a cycle between a measurement phase 64 and an ablation phase 63, a determination step 65 is used to decide when to stop the ablation process.
[0112] Measurement Phase
[0113] In the measurement phase 64 , voltage measurements resulting from the applied current are obtained and recorded for the electrical paths between the selected catheter electrodes (in this case, E1 and E2 ) and all external electrodes 1 .
[0114] As described above, multiple four-terminal voltage measurements are performed for each external point electrode 1 with respect to all neighboring electrodes. Figure 8 In a configuration of 4 (strip 4 consists of 64 electrodes arranged in four rows of 16 electrodes each), a total of 416 impedance measurements and paths are recorded (five for each electrode in the top and bottom strips, and eight for each electrode in the middle strip). With eight ADCs, all eight electrodes adjacent to the external point electrode 1 can be measured in a single cycle. Thus, for a single measurement duration of 2.5 ms, the duration of a complete measurement cycle will be 160 ms (2.5 ms x 64 = 160 ms). As will be appreciated, in this case, three of the eight ADCs will record empty measurements for the top and bottom row electrodes, which are automatically excluded from recording / analysis.
[0115] Figure 7The flowchart of FIG. 6 provides further details of the measurement phase 64. As will be appreciated, many steps of this process are similar to those described above with reference to FIG. Figure 6 The description is the same (and will not be described in detail here), however in embodiment 2 all impedance paths are measured and processed, rather than a pre-selected subset of the paths.
[0116] Note that while only results for current paths where the measurements show a decrease in impedance are used (step 54A), results for current paths where the impedance path measurements increase may also be processed to provide additional information. For example, such results may indicate that the catheter has moved between consecutive measurements.
[0117] At step 71, the previous Z of each measurement is calculated i start and the current Z i current The difference between ΔZ i The average slope ΔZ / Δt was measured during the first 30 seconds of ablation. 30sec (measured in ohms / second). At step 72, each measurement is calibrated using the following formula:
[0118]
[0119] The results are then subjected to further suitable processing (particularly, regression analysis) to determine the size of the lesion (and other features). In particular, some or all of the calibrated measurements are then used at step 73 to determine the size and orientation of the lesion. The measurements from each cycle are regressed relative to time to provide a logarithmic thermal rise curve for determining the size of the lesion. Orientation can be determined by associating the size of the lesion with the position of the external point electrode. This method eliminates the need for known impedance vs. depth and impedance vs. width curves as described above with reference to Example 1.
[0120] As will be appreciated, of all the impedance measurements made, the selection of the specific impedance measurement to be processed (and the specific calibrated measurement to be analyzed) will depend on a variety of different factors. This selection can be made under the control of computer software according to specified criteria (on a dynamic basis if desired).
[0121] like Figure 6 As schematically shown in , once the lesion size has been determined after the most recent ablation cycle, at decision step 65, the ablation therapy process ends (if the lesion is determined to be of the desired size), or (if not) the next iteration of ablation and measurement begins. As will be appreciated, determination step 65 may be bypassed after the initial measurement phase, before any ablation therapy has been applied.
[0122] Once the ablation is interrupted, further cycles of impedance measurement phases can be performed in order to monitor the rebound of impedance values. While impedance changes due to changes in tissue composition and structure are permanent, impedance changes due to temperature are not. Therefore, this post-ablation monitoring allows the generation and analysis of impedance recovery curves, providing valuable information about the mechanism and characteristics of the ablation performed.
[0123] The above examples of the present invention involve a four-terminal impedance measurement technique, which is a convenient method in low impedance sensing and avoids measurement errors due to contact and / or wire resistance. However, readers in the art will understand that the present invention can be implemented using other techniques, such as a 2-terminal or 3-terminal method.
[0124] In addition, in any of the above-described embodiments, the impedance measurement can be gated by the patient's respiratory cycle and ECG to provide measurements performed at relatively stable points. In this regard, the stable point is considered to be a time point 200ms after the first QRS after the "lung empty" indication from the ventilator 100. In particular, after the ablation phase, at the next stable point, the generator 12 is disconnected from the catheter and switched to the dummy load 25, whereby impedance measurements are performed. The duration of a typical ablation phase can be 3-5 seconds (within one respiratory cycle). In the case where the patient's respiratory rate is about 12 / m (i.e., 5s) and a typical ablation process takes between 30 seconds and 90 seconds, this will involve about 6-18 ablation / measurement cycles. As readers in the art will appreciate, alternative methods are possible. For example, multiple measurements (for all impedance paths) can be performed for each respiratory cycle, ideally gated by the patient's ECG.
[0125] As described elsewhere in this specification, while the described and illustrated embodiments conveniently use electrodes applied to the outside of the patient's body to provide current conducting terminals, other sites within the patient's body may also be suitable, provided they are sufficiently remote from the catheter electrodes and in contact with the patient. For example, these "external" electrodes may be appropriately placed within the esophagus and / or coronary sinus. When such an approach is used, an electroanatomical mapping system may be integrated with CT / MRI imaging to accurately determine the location of these "external electrode" sites within the anatomical volume.
[0126] Furthermore, the above description relates to RF ablation, but the method may also be used with other catheter ablation techniques, such as microwave radiation ablation. In such embodiments, the microwave radiation catheter may be equipped with one or more appropriately placed electrodes, such as saline electrodes or conventional metal electrodes.
[0127] As used herein, the term "comprise" and variations of the term such as "comprising", "containing" and "having" are not intended to exclude other additions, components, integers or steps, unless the context requires otherwise.
Claims
1. A system for monitoring the development of tissue damage during a medical ablation procedure applied to a patient, the system comprising: A catheter ablation device having at least one catheter electrode; The device is connectable to a source of electrical energy via an electrical feedthrough and is configured to apply ablative energy to ablate tissue in a target area; a plurality of external electrodes for application to the patient's body; measurement circuitry for determining an impedance of a current path between the at least one catheter electrode and the external electrode in the absence of application of the ablation energy; as well as an electrical controller arranged to control sequential application of an AC current source between different combinations of the at least one catheter electrode and the plurality of external electrodes such that measurement of the resulting voltages provides a measure of the impedance of different current paths through the patient's body between the respective electrodes; in The measurement circuit comprises a switch matrix arranged to switch between different combinations of the at least one catheter electrode and the plurality of external electrodes to form the different current paths under the control of the electrical controller; The measuring circuit is used to measure the impedances of the different current paths respectively to obtain the measurement results of the impedances of the different current paths; the measurement results are used to select one or more current paths from the different current paths; Electrodes used to monitor the progression of tissue damage are selected based on the one or more current paths.
2. The system of claim 1, wherein: The electrical controller is also configured to disconnect the catheter ablation device from the source of electrical energy or otherwise suspend the application of ablation energy during application of the AC current source. 3 . The system of claim 1 , comprising a virtual resistive load for selectively connecting to the source of electrical energy during an operation period of the measurement circuit.
4. The system according to claim 1, wherein: The catheter ablation device has at least two catheter electrodes, and the measurement circuit is configured to perform four-terminal impedance sensing by applying a current between one of the plurality of external electrodes and the first catheter electrode and measuring a voltage between another of the plurality of external electrodes and the second catheter electrode.
5. The system of claim 1, comprising a plurality of analog-to-digital converters (ADCs) for simultaneously measuring different current paths.
6. The system according to claim 1, wherein: The source of electrical energy is an RF generator.
7. A system according to any one of the preceding claims, wherein: The plurality of external electrodes are arranged as electrode point lacing for application across an external region of the patient's body.
8. A method of operating a measurement system for an intermittent catheter ablation procedure applied to tissue of a subject, the method comprising: performing a measurement phase during the intermittent catheter ablation procedure at times when ablation is not being applied to the tissue, the measurement phase involving using the measurement system to measure an impedance of a current path through a lesion region formed by the ablation; in The measurement system is configured to monitor tissue damage development during the intermittent catheter ablation procedure and comprises: A catheter ablation device having at least one catheter electrode; a plurality of external electrodes for application to the subject's body; measurement circuitry for determining an impedance of a current path between the at least one catheter electrode and the external electrode in the absence of applied ablative energy; and An electrical controller, wherein The measuring phase is performed using the electrical controller, the at least one catheter electrode, the plurality of external electrodes, and the measuring circuit; The method further includes a determination phase, in which one or more current paths are selected from the multiple current paths by sequentially applying current between one or more catheter electrodes and different combinations of one or more external electrodes among the multiple external electrodes to form multiple current paths, and using the measurement circuit to measure the impedances of the multiple current paths respectively to obtain measurement results of the impedances of the multiple current paths, and electrodes for the measurement phase are selected based on the one or more current paths.
9. The method according to claim 8, wherein: During the measurement phase, ablation energy to be applied to the tissue is transferred from the catheter electrode to a dummy load.
10. The method according to claim 8, wherein: In the determination phase a defined number of current paths are selected, wherein the associated electrodes are used for a subsequent iteration of the measurement phase.
11. The method according to claim 8, wherein: The electrodes are selected as those associated with the lowest impedance of the measured current path.
12. The method according to claim 8, wherein: The measurements obtained in the measuring phase are used in an algorithm to estimate the size of the lesion formed in the determining phase.
13. The method according to claim 12, wherein: For each measurement phase, the measurement results are analyzed and a selection is made as to which measurement results are used in the algorithm.
14. The method according to claim 13, wherein: The selection is made based at least in part on a change in the electrical characteristics of the associated current path since a previous measurement phase.
15. The method according to any one of claims 8 to 14, wherein: The determination phase and / or the measurement phase are gated by the breathing cycle and / or the heartbeat of the subject.
Citation Information
Patent Citations
Methods and apparatuses for treating auto-immune diseases by ablative neuromodulation
CN105263432A
Switching methods and apparatus
US20080183169A1
System and method for assessing lesions in tissue
US20130226169A1
Systems and Methods of Radiometrically Determining a Hot-Spot Temperature of Tissue Being Treated
US20150105765A1
